Targeting ageing in COVID-19 patients to prevent respiratory failure
- Funded by UFM Denmark
- Total publications:0 publications
Grant number: unknown
Grant search
Key facts
Disease
COVID-19Known Financial Commitments (USD)
$297,936.16Funder
UFM DenmarkPrincipal Investigator
Associate Professor Morten Scheibye-KnudsenResearch Location
DenmarkLead Research Institution
Center for Healthy Aging, Dpt. of Cellular and Molecular Medicine, University of CopenhagenResearch Priority Alignment
N/A
Research Category
Clinical characterisation and management
Research Subcategory
Prognostic factors for disease severity
Special Interest Tags
N/A
Study Type
Clinical
Clinical Trial Details
Unspecified
Broad Policy Alignment
Pending
Age Group
Adults (18 and older)Older adults (65 and older)
Vulnerable Population
Unspecified
Occupations of Interest
Unspecified
Abstract
The mortality rate of 80-year- old COVID-19 patients is about 100 times greater than that of a 30-year-old patients. This project will treat older patients with a substance similar to vitamin B and Will investigate what factors make elderly people vulnerable to COVID-19. All in all, the project may lead to a possible treatment of COVID- 19 and an understanding of why elderly people are so particularly vulnerable to this virus.